Comparison of the efficacy of different mTOR inhibitors for the treatment of prostate cancer

被引：0
|
作者：
D'Abronzo, Leandro Salati
Beggs, Ryan
Bose, Swagata
Ghosh, Paramita
机构：
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1158/1078-0432.MECHRES-A52
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A52
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer
    Uglyanitsa, KN
    Nefyodov, LI
    Doroshenko, YM
    Brzosko, WJ
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2000, 26 (5-6) : 201 - 221
  • [22] The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients
    Yurova, M. N.
    ADVANCES IN GERONTOLOGY, 2020, 10 (03) : 287 - 291
  • [23] Future perspectives for mTOR inhibitors in renal cell cancer treatment
    Czarnecka, Anna M.
    Kornakiewicz, Anna
    Lian, Fei
    Szczylik, Cezary
    FUTURE ONCOLOGY, 2015, 11 (05) : 801 - 817
  • [24] The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients
    M. N. Yurova
    Advances in Gerontology, 2020, 10 : 287 - 291
  • [25] Protein kinase inhibitors for the treatment of prostate cancer
    Chau, Vincent
    Madan, Ravi A.
    Aragon-Ching, Jeanny B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1889 - 1899
  • [26] PARP inhibitors and stratified treatment of prostate cancer
    Lavery, Anita
    Gilson, Clare
    Chowdhury, Simon
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1213 - 1215
  • [27] BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
    Asangani, Irfan A.
    Wilder-Romans, Kari
    Dommeti, Vijaya L.
    Krishnamurthy, Pranathi M.
    Apel, Ingrid J.
    Escara-Wilke, June
    Plymate, Stephen R.
    Navone, Nora M.
    Wang, Shaomeng
    Feng, Felix Y.
    Chinnaiyan, Arul M.
    MOLECULAR CANCER RESEARCH, 2016, 14 (04) : 324 - 331
  • [28] Physicochemical properties and biological efficacy of 30 DYRK2 Inhibitors for the treatment of prostate cancer
    Joshi, Sravani
    Srivastava, Ruby
    VIETNAM JOURNAL OF CHEMISTRY, 2024, 62 (05) : 624 - 633
  • [29] Different guidelines for treatment of prostate cancer
    Spigset, Olav
    Samdal, Hilde
    Harg, Pernille
    Werner, Maren C. Frogner
    Fjermeros, Kamilla
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (14) : 1221 - 1221
  • [30] Different guidelines for treatment of prostate cancer
    Solberg, Arne
    Angelsen, Anders
    Berge, Viktor
    Lilleby, Wolfgang
    Iversen, Jon
    Klepp, Olbjorn
    Brennhovd, Bjorn
    Johannessen, Dag
    Nygard, Yngve
    Larsen, Kari
    Stensvold, Andreas
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (12-13) : 1105 - 1105
12345